Myovant Sciences Ltd. Common Shares (MYOV): Stock Offering News

MYOV – Commences underwritten public offering of $75 mln of its common shares.


Key Facts Surrounding This News Item


  • MYOV had a POWR Rating of B (Buy) coming into today.
  • MYOV was -0.13% below its 10-Day Moving Average coming into today.
  • MYOV was -0.18% below its 20-Day Moving Average coming into today.
  • MYOV was 5.22% above its 50-Day Moving Average coming into today.
  • MYOV was 15.19% above its 100-Day Moving Average coming into today.
  • MYOV was 38.82% above its 200-Day Moving Average coming into today.
  • MYOV had returned +86.71% year-to-date leading up to today’s news, versus a +5.40% return from the benchmark S&P 500 during the same period.

More Info About Myovant Sciences Ltd. Common Shares (MYOV)


Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women’s health diseases and other endocrine-related disorders. The company was founded in 2016 and is based in Hamilton, Bermuda. View our full MYOV ticker page with ratings, news, and more.

MYOV at a Glance

MYOV Current POWR Rating™
Overall POWR Rating™
MYOV Current Price $18.64 1.97%
More MYOV Ratings, Data, and News

MYOV Price Reaction

The day of this event (Jul. 11, 2018)
MYOV Closing Price$24.10 2.12%
MYOV Volume65,900
16.74% from avg
Leading up to this event
MYOV 1-mo return7.86%
After this event
MYOV 1-day return2.39%
MYOV 3-day return15.18%
MYOV 5-day return16.66%

MYOV Price Chart



More Myovant Sciences Ltd. Common Shares (MYOV) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MYOV News
Page generated in 0.9126 seconds.